[1]
M. Pavlović, D. Buljan, and A. Bonevski, “Targeted therapy with entrectinibin children with NTRK rearrangedmesenchymal neoplasms”, Paediatr Croat, vol. 68, no. 2, pp. 103–106, Jul. 2024, doi: 10.13112/PC.2024.15.